Association of Radiotherapy for Prostate Cancer and Second Primary Colorectal Cancer: a US Population-based Analysis

Overview

Journal Tech Coloproctol

Date 2023 Dec 14

PMID 38095784

Authors

W Tang

L-J Zhou

W-Q Zhang

Y-J Jia

M-W Ge

F-H Hu

H-L Chen

Affiliations

Soon will be listed here.

Abstract

Background: Radiotherapy (RT) is a common treatment for prostate cancer, yet the risk of second primary colorectal cancer (SPCRC) in patients with prostate cancer undergoing RT has not been adequately studied.

Methods: This study employed a population-based cohort design using the US Surveillance, Epidemiology, and End Results (SEER) database to identify individuals diagnosed between January 1975 and December 2015. The cumulative incidence of SPCRC was estimated using Fine-Gray competing risk regression. Poisson regression analysis was used to estimate the risk associated with RT. Survival outcomes of patients with SPCRC were evaluated using the Kaplan-Meier method.

Results: A total of 287,607 patients diagnosed with prostate cancer were identified. The cumulative incidences were higher in patients who did not receive RT (2.00%) compared to those who underwent RT (2.47%) after 25 years. After adjustment for multiple variables, RT was associated with an increased risk of developing combined SPCRC (adjusted HR 1.590). Additionally, the overall survival was significantly lower in patients who developed colorectal cancer after receiving RT as compared to those who did not receive RT.

Conclusion: These findings underscore the need for diligent long-term monitoring and effective management strategies to detect SPCRC in patients treated with RT for prostate cancer.

Citing Articles

Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy.

Qiu Y, Cao N, Meng D, Yuan J, Zhu Y Sci Rep. 2025; 15(1):4045.

PMID: 39900612 PMC: 11790972. DOI: 10.1038/s41598-025-88555-7.

References

Sachdev S, Carroll P, Sandler H, Nguyen P, Wafford E, Auffenberg G . Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review. JAMA Oncol. 2020; 6(11):1793-1800. DOI: 10.1001/jamaoncol.2020.2832. View

Wang Y, Ai Q, Zhao W, Gao Y, Liu Q, Shi T . Safety and Reliability of a Robot-assisted Laparoscopic Telesurgery System: Expanding Indications in Urological Surgery. Eur Urol. 2023; 85(5):506-507. DOI: 10.1016/j.eururo.2023.11.002. View

Wennstig A, Wadsten C, Garmo H, Johansson M, Fredriksson I, Blomqvist C . Risk of primary lung cancer after adjuvant radiotherapy in breast cancer-a large population-based study. NPJ Breast Cancer. 2021; 7(1):71. PMC: 8169889. DOI: 10.1038/s41523-021-00280-2. View

Stenmark M, Conlon A, Johnson S, Daignault S, Litzenberg D, Marsh R . Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer. Radiother Oncol. 2014; 110(2):291-7. DOI: 10.1016/j.radonc.2014.01.007. View

Pithadia K, Advani P, Citrin D, Bekelman J, Withrow D, Berrington de Gonzalez A . Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015. JAMA Oncol. 2023; 9(8):1119-1123. PMC: 10251240. DOI: 10.1001/jamaoncol.2023.1638. View

Hegemann N, Schlesinger-Raab A, Ganswindt U, Horl C, Combs S, Holzel D . Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis. Radiat Oncol. 2017; 12(1):2. PMC: 5209816. DOI: 10.1186/s13014-016-0738-z. View

Rombouts A, Hugen N, van Beek J, Poortmans P, de Wilt J, Nagtegaal I . Does pelvic radiation increase rectal cancer incidence? - A systematic review and meta-analysis. Cancer Treat Rev. 2018; 68:136-144. DOI: 10.1016/j.ctrv.2018.05.008. View

Davis E, Beebe-Dimmer J, Yee C, Cooney K . Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer. 2014; 120(17):2735-41. PMC: 4195444. DOI: 10.1002/cncr.28769. View

Bhojani N, Capitanio U, Suardi N, Jeldres C, Isbarn H, Shariat S . The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys. 2010; 76(2):342-8. DOI: 10.1016/j.ijrobp.2009.02.011. View

10.

Moschini M, Zaffuto E, Karakiewicz P, D Andrea D, Foerster B, Abufaraj M . External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol. 2018; 75(2):319-328. DOI: 10.1016/j.eururo.2018.09.034. View

11.

Omer D, Thompson H, Verheij F, Yuval J, Rosen R, Beets N . Rectal Cancer after Prostate Radiation: A Complex and Controversial Disease. Cancers (Basel). 2023; 15(8). PMC: 10136617. DOI: 10.3390/cancers15082214. View

12.

Zhu Z, Zhao S, Liu Y, Wang J, Luo L, Li E . Risk of secondary rectal cancer and colon cancer after radiotherapy for prostate cancer: a meta-analysis. Int J Colorectal Dis. 2018; 33(9):1149-1158. DOI: 10.1007/s00384-018-3114-7. View

13.

Bagshaw H, Arnow K, Trickey A, Leppert J, Wren S, Morris A . Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer. JAMA Netw Open. 2022; 5(7):e2223025. PMC: 9335142. DOI: 10.1001/jamanetworkopen.2022.23025. View

14.

Thompson I, Valicenti R, Albertsen P, Davis B, Goldenberg S, Hahn C . Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol. 2013; 190(2):441-9. DOI: 10.1016/j.juro.2013.05.032. View

15.

Lakkis Z, Vernerey D, Mege D, Faucheron J, Panis Y, Tuech J . Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy. Br J Surg. 2019; 106(8):1087-1098. DOI: 10.1002/bjs.11176. View

16.

Hinnen K, Schaapveld M, van Vulpen M, Battermann J, van der Poel H, van Oort I . Prostate brachytherapy and second primary cancer risk: a competitive risk analysis. J Clin Oncol. 2011; 29(34):4510-5. DOI: 10.1200/JCO.2011.35.0991. View

17.

Pan C, Ziogas A, Buchberg B, Raj K, Mills S, Stamos M . Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer. Dis Colon Rectum. 2011; 54(5):526-34. DOI: 10.1007/DCR.0b013e31820939fb. View

18.

Schaake W, Wiegman E, de Groot M, van der Laan H, van der Schans C, van den Bergh A . The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients. Radiother Oncol. 2014; 110(2):284-90. DOI: 10.1016/j.radonc.2013.11.011. View

19.

Samadder N, Smith K, Hanson H, Pimentel R, Wong J, Boucher K . Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis. Clin Gastroenterol Hepatol. 2015; 13(13):2305-11.e1-2. DOI: 10.1016/j.cgh.2015.06.040. View

20.

Samadder N, Smith K, Mineau G, Pimentel R, Wong J, Boucher K . Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther. 2015; 41(6):573-80. DOI: 10.1111/apt.13086. View